@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix Protein: . @prefix mgi: . @prefix geneProductOf: . @prefix RNA: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: mgi:96995; a Protein: . sub:_2 geneProductOf: mgi:87909; a RNA: . sub:_3 occursIn: obo:CL_0000057, species:10090; rdf:object sub:_2; rdf:predicate belv:decreases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "p(MGI:Kmt2a) -| r(MGI:Acta2)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_5; pav:version "20131211" . sub:_4 prov:value "Verification of differential gene expression by RT–PCR. Several identified target genes were tested by semiquantitative RT– PCR experiment using 25–35 cycles. (a) RT–PCR of potential target genes overexpressed in MLL -/- cells A: mRNA for vascular smooth muscle a-actin (#2 of 40); B: RBP associated molecule RAM14-1 mRNA (#6of 40); C: Serine protease inhibitor 4 (#4 of 40); D: Four and a half LIM domain 1 (#21 of 40); E: TOB (#40 of 40)."; prov:wasQuotedFrom pubmed:12789274 . sub:_5 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:12789274; prov:wasDerivedFrom beldoc:, sub:_4 . } sub:pubinfo { this: dct:created "2014-07-03T14:32:02.944+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }